4 Results for "

U118MG

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "U118MG" in MCE Product Catalog:

Cat. No.: HY-178969
Target:  

FAK Pyk2 Apoptosis

Research Areas:  

Neurological Disease Cancer

GZD-257 is a brain-penetrant, ATP-competitive FAK inhibitor (IC50 = 14.3 nM), performing 4.77-fold selectivity with FAK to Pyk2 (IC50 = 68.2 nM). GZD-257 can significantly induce apoptosis of U118MG cells and arrest the cell cycle at the G2/M phase. GZD-257 can be used for the study of Glioblastoma (GBM) .
loading...
    loading...
Cat. No.: HY-187711
Research Areas:  

Neurological Disease Cancer

FAK-IN-33 is a potent focal adhesion kinase (FAK) inhibitor with an IC50 value of 10.23 nM against FAK. FAK-IN-33 inhibits the viability of U118-MG glioblastoma cells with an IC50 of 0.29 μM, and shows low cytotoxicity toward LO2 and 2BS cells. FAK-IN-33 can be used in studies related to glioblastoma .
loading...
    loading...
Cat. No.: HY-181717
CAS No.: 3098518-95-4
TKL002 is a blood-brain barrier-permeable inhibitor of the CTH/H2S/NF-κB/EMT signaling axis. TKL002 induces G2/M phase cell cycle arrest and apoptosis in glioblastoma cells. TKL002 inhibits the migration and invasion of glioblastoma cells by upregulating E-cadherin and downregulating N-cadherin and vimentin. TKL002 is applicable to relevant research on glioblastoma .
loading...
    loading...
Cat. No.: HY-187210
CAS No.: 2271229-98-0
Target:  

HDAC Apoptosis

Research Areas:  

Cancer

HDAC6-IN-86 is a histone deacetylase 6 (HDAC6) inhibitor with an IC50 of 74 nM, and it exhibits high selectivity for HDAC1. HDAC6-IN-86 induces cell apoptosis, triggers G2/M phase cell cycle arrest, and inhibits the proliferation of glioma cells. HDAC6-IN-86 can be used for the research of glioblastoma multiforme (GBM) .
loading...
    loading...